Showing results (291-300 of 334) with videos related to

Sort By:
Pageof 34
Blood|January 25, 2015
Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCTJudith Feucht, Kathrin Opherk, Peter Lang, et al.
British Journal of Haematology|December 6, 2017
CD34<sup>+</sup> selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantationChiara Mainardi, Martin Ebinger, Sigrid Enkel, et al.
Multiple Sclerosis and Related Disorders|December 3, 2025
Outcomes of autologous stem cell transplantation in patients with multiple sclerosis: A United Arab Emirates experienceRuqqia Mir, Fatima Al-Kaabi, Lev Brylev, et al.
Blood|May 30, 2014
HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disordersAlice Bertaina, Pietro Merli, Sergio Rutella, et al.
Blood|April 21, 2012
Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemiaWing Leung, Ching-Hon Pui, Elaine Coustan-Smith, et al.
Journal of Clinical Apheresis|September 29, 2025
Double Filtration Plasmapheresis for Environmental Toxin Removal: A Case Series of Patients With Hyperlipoproteinemia(a)Yandy Marx Castillo-Aleman, Carlos Agustin Villegas-Valverde, Maysoon Al-Karam, et al.
Blood Advances|January 30, 2024
Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCTClaus-Philipp Maier, Chihab Klose, Christian Martin Seitz, et al.
Cancers|January 11, 2025
Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort StudyTim Flaadt, Jonas Rehm, Thorsten Simon, et al.
Scientific Reports|November 15, 2018
Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosisA K M Ashiqul Haque, Alexander Dewerth, Justin S Antony, et al.
Nature Communications|December 2, 2021
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancerClemens Hinterleitner, Jasmin Strähle, Elke Malenke, et al.
Pageof 34